ADVFN Logo ADVFN

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,954.50
1.59%
US Tech 100
20,332.80
1.61%
Dow Jones
43,840.91
1.39%
Brent Oil
73.045
0.00%
Bitcoin
85,823.43
1.72%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Lucid Diagnostics Inc (LUCD) Quote

Lucid Diagnostics Inc

Lucid Diagnostics Inc (LUCD)

NASDAQ
1.48
-0.02
(-1.33%)
Closed March 01 4:00PM
Delayed by 15 minutes
1.50
0.02
(1.35%)
After Hours: 5:32PM
Delayed by 15 minutes
Advanced chart

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
1.50
Bid
1.18
Ask
1.55
Volume
354,228
1.441 Day's Range 1.5494
0.6301 52 Week Range 1.633
Market Cap
89.014M
Previous Close
1.50
Open
1.51
Last Trade
12
@
1.5
Last Trade Time
Financial Volume
$ 529,652
VWAP
1.4952
Average Volume (3m)
522,771
Shares Outstanding
59,342,479
Dividend Yield
-
PE Ratio
-1.66
Earnings Per Share (EPS)
-0.89
Revenue
2.43M
Net Profit
-52.67M

About Lucid Diagnostics Inc

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease, also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically hig... Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease, also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard. Show more

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Headquarters
Wilmington, Delaware, USA
Founded
-
Lucid Diagnostics Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker LUCD. The last closing price for Lucid Diagnostics was $1.50. Over the last year, Lucid Diagnostics shares have traded in a share price range of $ 0.6301 to $ 1.633.

Lucid Diagnostics currently has 59,342,479 shares outstanding. The market capitalization of Lucid Diagnostics is $89.01 million. Lucid Diagnostics has a price to earnings ratio (PE ratio) of -1.66.

Ask ADVFN Intelligence (AI)

LUCD Latest News

More News

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
February 21 2025
LUCD (-1.33%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
February 21 2025
LUCD (-1.33%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
February 21 2025
LUCD (-1.33%)

Form S-8 - Securities to be offered to employees in employee benefit plans
Edgar (US Regulatory)
January 31 2025
LUCD (-1.33%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.02-1.315789473681.521.591.158061611.4397399CS
40.570161.30766749110.92991.6330.8858286661.34932098CS
120.63473.21016166280.8661.6330.75015227711.11302001CS
260.65176.67844522970.8491.6330.734243541.02574347CS
520.1712.78195488721.331.6330.63013094650.98355535CS
156-2.06-57.86516853933.563.930.63011579331.32772702CS
260-11.25-88.235294117612.7513.50.63011713722.37862175CS

LUCD - Frequently Asked Questions (FAQ)

What is the current Lucid Diagnostics share price?
The current share price of Lucid Diagnostics is $ 1.50
How many Lucid Diagnostics shares are in issue?
Lucid Diagnostics has 59,342,479 shares in issue
What is the market cap of Lucid Diagnostics?
The market capitalisation of Lucid Diagnostics is USD 89.01M
What is the 1 year trading range for Lucid Diagnostics share price?
Lucid Diagnostics has traded in the range of $ 0.6301 to $ 1.633 during the past year
What is the PE ratio of Lucid Diagnostics?
The price to earnings ratio of Lucid Diagnostics is -1.66
What is the cash to sales ratio of Lucid Diagnostics?
The cash to sales ratio of Lucid Diagnostics is 35.94
What is the reporting currency for Lucid Diagnostics?
Lucid Diagnostics reports financial results in USD
What is the latest annual turnover for Lucid Diagnostics?
The latest annual turnover of Lucid Diagnostics is USD 2.43M
What is the latest annual profit for Lucid Diagnostics?
The latest annual profit of Lucid Diagnostics is USD -52.67M
What is the registered address of Lucid Diagnostics?
The registered address for Lucid Diagnostics is CORPORATION TRUST CENTER 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
Which industry sector does Lucid Diagnostics operate in?
Lucid Diagnostics operates in the SURGICAL,MED INSTR,APPARATUS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
STAKSTAK Inc
$ 3.97
(156.13%)
173.35k
ORGOOrganogenesis Holdings Inc
$ 6.21
(102.28%)
58.69M
TRNRInteractive Strength Inc
$ 2.57
(67.97%)
192.48M
PMAXPowell Max Ltd
$ 0.511
(43.54%)
136.35M
ARBBARB IOT Group Ltd
$ 0.6635
(38.23%)
58.86M
NVNINVNI Group Ltd
$ 0.99
(-50.50%)
72.28M
SPGCSacks Parente Golf Inc
$ 0.2085
(-48.65%)
57.4M
ADGMAdagio Medical Holdings Inc
$ 0.8081
(-47.53%)
756.64k
PRAXPraxis Precision Medicines Inc
$ 38.60
(-40.64%)
3.17M
SAGSAG Holdings Ltd
$ 1.19
(-38.97%)
788.89k
NVDANVIDIA Corporation
$ 124.92
(3.97%)
389.48M
TRNRInteractive Strength Inc
$ 2.57
(67.97%)
193.57M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 13.44
(7.78%)
154.46M
PMAXPowell Max Ltd
$ 0.511
(43.54%)
137.18M
LCIDLucid Group Inc
$ 2.22
(-0.45%)
136.17M

LUCD Financials

Financials

LUCD Discussion

View Posts
georgie18 georgie18 4 months ago
LUCD...$1.08...Off my .90 alert...🥳

georgie18

Member Level
Re: georgie18 post# 384972

Thursday, November 07, 2024 8:57:15 AM

Post#
385327
of 385451
LUCD...$1.05...🥳...NEW YORK, Nov. 7, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that the manuscript for its multicenter ESOGUARD BE-1 study has been accepted for publication in The American Journal of Gastroenterology, the official journal of the American College of Gastroenterology (ACG). This is the fourth publication presenting clinical validation data for Lucid's EsoGuard® Esophageal DNA Test, and the second to demonstrate its strong performance in an intended-use screening population. Consistent with previous studies, EsoGuard showed high sensitivity and negative predictive value in detecting esophageal precancer (Barrett's Esophagus or BE).

georgie18

Member Level
Re: None

Tuesday, October 29, 2024 9:48:42 AM

Post#
6
of 7
LUCD...9621...Trying Red to Green here...🥳

georgie18

Member Level
Re: None

Tuesday, October 29, 2024 8:23:21 AM

Post#
384965
of 384971
LUCD...90 ...https://schrts.co/DyzNKhGQ ...Break/hold 98 and I think she will rip...🥳
👍️0
chemist72 chemist72 4 months ago
What is the MoIDX Medicare Program?
https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdid=35025
👍️0
georgie18 georgie18 4 months ago
LUCD...$1.05...🥳...NEW YORK, Nov. 7, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that the manuscript for its multicenter ESOGUARD BE-1 study has been accepted for publication in The American Journal of Gastroenterology, the official journal of the American College of Gastroenterology (ACG). This is the fourth publication presenting clinical validation data for Lucid's EsoGuard® Esophageal DNA Test, and the second to demonstrate its strong performance in an intended-use screening population. Consistent with previous studies, EsoGuard showed high sensitivity and negative predictive value in detecting esophageal precancer (Barrett's Esophagus or BE).

georgie18

Member Level
Re: None

Tuesday, October 29, 2024 9:48:42 AM

Post#
6
of 7
LUCD...9621...Trying Red to Green here...🥳

georgie18

Member Level
Re: None

Tuesday, October 29, 2024 8:23:21 AM

Post#
384965
of 384971
LUCD...90 ...https://schrts.co/DyzNKhGQ ...Break/hold 98 and I think she will rip...🥳
👍️0
georgie18 georgie18 4 months ago
LUCD...9621...Trying Red to Green here...🥳

georgie18

Member Level
Re: None

Tuesday, October 29, 2024 8:23:21 AM

Post#
384965
of 384971
LUCD...90 ...https://schrts.co/DyzNKhGQ ...Break/hold 98 and I think she will rip...🥳
👍️0
georgie18 georgie18 4 months ago
LUCD...90 ...https://schrts.co/DyzNKhGQ ...Break/hold 98 and I think she will rip...🥳
👍️0
Monksdream Monksdream 12 months ago
LUCD new 52 lo
👍️0
Monksdream Monksdream 1 year ago
LUCD new 52 week low
👍️0
ErnieBilco ErnieBilco 3 years ago
Should have listened to the chart telling me lower but I bought some at $2.39 and $2.21 for a starter. It has a $9+ PT
👍️0
makinezmoney makinezmoney 3 years ago
$LUCD: Not the EV Car Company...............


But you can easily get confused.



Now at $7.30 here in PreMarket



https://www.luciddx.com/





GO $LUCD
👍️0

Your Recent History

NASDAQ
LUCD
Lucid Diagnostics
BIT
UC92U8
Unicredit Bank
BIT
ASML
ASML Holding NV
AQSE
GDH
Gledhow Investments
BIT
ACE
Acea
EU
BNOBD
Novo Banco SA Bond 4.222...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads